Comparison of colonic transit time between patients with constipation-predominant irritable bowel syndrome and functional constipation

被引:11
|
作者
Ansari R. [1 ]
Sohrabi S. [1 ]
Ghanaie O. [1 ]
Amjadi H. [1 ]
Merat S. [1 ]
Vahedi H. [1 ]
Khatibian M. [1 ]
机构
[1] Digestive, Disease Research Center, Shariati Hospital, Tehran University of Medical Sciences, 14117 Tehran, North Kargar Avenue
关键词
Bowel motility; Functional bowel disease;
D O I
10.1007/s12664-010-0015-2
中图分类号
学科分类号
摘要
Background/Aim Functional constipation (FC) and consti-pation-predominant IBS (C-IBS) are two main subtypes of constipation. Using radio-opaque markers is an easy and cost effective method to measure colonic transit time (CTT). We designed this study to compare the CTT between these two groups of constipated patients. Methods Patients with chronic constipation of no organic etiology were classified as having FC or C-IBS according to the Rome II criteria. All patients ingested 10 radio opaque markers daily for six days. A plain abdominal X-ray was taken on the seventh day. To calculate the total and segmental colonic transit time in hours, number of markers in right and left colonic and rectosigmoid area were counted and multiplied by 2.4. The mean total and segmental colonic transit time were compared between the two groups. Results A total of 100 patients (50 FC and 50 C-IBS) were enrolled. The mean (SD) total CTT was not significantly different between FC patients (52.2 [35.5] h) and C-IBS patients (41.2 [31.6] h; p = 0.10). The mean rectosigmoid transit time was significantly slower in FC patients (19.9 [15.5] h) com-pared to C-IBS patients (11.9 [10.6] h; p = 0.003). Conclusion Rectosigmoid transit time in FC patients is slower than in C-IBS patients.
引用
收藏
页码:66 / 68
页数:2
相关论文
共 50 条
  • [11] Lubiprostone In Constipation-Predominant Irritable Bowel Syndrome
    Carter, Natalie J.
    Scott, Lesley J.
    [J]. DRUGS, 2009, 69 (09) : 1229 - 1237
  • [12] Tegaserod for constipation-predominant irritable bowel syndrome
    Kale-Pradhan, Pramodini B.
    Wilhelm, Sheila M.
    [J]. PHARMACOTHERAPY, 2007, 27 (02): : 267 - 277
  • [13] POSTPRANDIAL COLONIC HYPERACTIVITY IN PATIENTS WITH CONSTIPATION-PREDOMINANT IRRITABLE-BOWEL-SYNDROME (IBS)
    VONDEROHE, M
    CAMILLERI, M
    TALLEY, NJ
    PHILLIPS, SF
    [J]. GASTROENTEROLOGY, 1993, 104 (04) : A595 - A595
  • [14] Diarrhea- and constipation-predominant irritable bowel syndrome
    Richard Lea
    Peter J. Whorwell
    [J]. Current Treatment Options in Gastroenterology, 2001, 4 (4) : 299 - 308
  • [15] Comparison of Quality of Life Between Patients With Diarrhea- and Constipation-Predominant Irritable Bowel Syndrome
    BouSaba, Joelle
    Dilmaghani, Saam
    Taylor, Ann
    Busciglio, Irene
    Camilleri, Michael
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S405 - S405
  • [16] Significance of Rome II-defined functional constipation in Taiwan and comparison with constipation-predominant irritable bowel syndrome
    Lu, C. -L.
    Chang, F. -Y.
    Chen, C. -Y.
    Luo, J. -C.
    Lee, S. -D.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (02) : 429 - 438
  • [17] Polyethylene Glycol in Constipation-Predominant Irritable Bowel Syndrome
    Shearer, Jessica
    Ford, Alexander C.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (01): : 135 - 135
  • [18] Antibiotic Treatment of Constipation-Predominant Irritable Bowel Syndrome
    Mark Pimentel
    Christopher Chang
    Kathleen Shari Chua
    James Mirocha
    John DiBaise
    Satish Rao
    Meridythe Amichai
    [J]. Digestive Diseases and Sciences, 2014, 59 : 1278 - 1285
  • [19] Colonoscopic features of functional constipation and constipation-predominant irritable bowel syndrome (IBS-C)
    Takeshi, M.
    Hidekazu, S.
    Toshifumi, H.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2011, 23 : 21 - 22
  • [20] The management of constipation-related functional gastrointestinal disorder (constipation-predominant irritable bowel syndrome)
    Amal F. Radwan
    Nagwa R. Ahmed
    Eman A. Sultan
    [J]. The Egyptian Journal of Internal Medicine, 2015, 27 (4) : 127 - 132